… Parkinson and Movement Disorder Society (MDS) task force comprising experts from four continents published recently in the journal Movement Disorders presents a tool that reflects our current understanding. The Michael J. … We want these criteria to be able to be applied everywhere. MJFF: What can you tell us about the prodromal …

… Study Rationale: Currently, there is no way to predict whether a person will develop Parkinson's disease … PD can be calculated using a mathematical formula that combines the individual influences of the five specific risk … Improved Biomarkers and Clinical Outcome Measures …

… with Young Onset Parkinson’s at age 47, but her symptoms began in her late 30′s. Having always been an optimist, … to walk normally. I was already doing Treadmill exercises recommended by another speaker at the same Conference, so I … all day. Maybe I'll get my built in ruler back. (Honey, where's the chalk?) Hmm, I wonder what ever happened to that …

… uncertainty of the unknown was far more stressful. In order to protect her privacy, Joann has asked that we omit her … wrong," shares Joann, who went through multiple doctor visits and tests before discovering she has Parkinson's. … or characteristic in the body that helps track the presence or progression of a disease. If we were to discover …

… Sharing Pioneer Award. Dr. Diane Stephenson, executive director of CPP, presented the award to the Foundation in recognition of our commitment to access and usability in research data. Dr. … Institutes of Health, which plans to open its public data portal this year. Luba Smolensky, Director of Research …

… development against this target. Alpha-synuclein clumps into, scientists believe, toxic aggregates that damage cells in Parkinson's disease (PD). Preventing or breaking up those clumps may prevent, slow or … more specific targeting of the protein and development of tests to assess whether therapies are hitting the right …